Solomon Langermann

6PUBLICATIONS
63CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2025
NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression.

Thejaswini Giridharan, Sora Suzuki, Anm Nazmul H Khan

|Apr 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity.

Tianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng

|Mar 01, 2024
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies.

Kushal Prajapati, Chuan Yan, Qiqi Yang

|Jul 19, 2023
Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia.

Claire E Pillsbury, Jodi Dougan, Jennifer L Rabe

|Mar 24, 2023
Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer.

Thazin N Aung, Niki Gavrielatou, Ioannis A Vathiotis

|Jun 15, 2018
B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex.

Joseph R Podojil, Ming-Yi Chiang, Igal Ifergan

Pageof 1

Frequent Collaborators

4 joint publications

Dallas Flies

2 joint publications

Linda N Liu

1 joint publications

Joseph R Podojil

1 joint publications

Dario A A Vignali